Secura Bio

Henderson, United States Founded: 2018 • Age: 8 yrs
Consulting services for market access and health outcomes are provided.
Request Access

About Secura Bio

Secura Bio is a company based in Henderson (United States) founded in 2018.. Secura Bio has raised $55 million across 2 funding rounds from investors including Athyrium Capital Management. Secura Bio offers products and services including COPIKTRA. Secura Bio operates in a competitive market with competitors including OPEN Health, Target RWE, Abacus Medicine, STATinMED Research and Hylant, among others.

  • Headquarter Henderson, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Secura Bio, Inc
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $55 M (USD)

    in 2 rounds

  • Latest Funding Round
    $55 M (USD), Series A

    Mar 13, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Secura Bio

Secura Bio offers a comprehensive portfolio of products and services, including COPIKTRA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Medication for treating certain cancers and blood disorders.

People of Secura Bio
Headcount 10-50
Employee Profiles 12
Board Members and Advisors 1
Employee Profiles
People
Christiane Langer M.D.
Senior Vice President , Head Of Clinical & Medical Affairs
People
Gregory S. Wessels
VP, Global Marketing
People
Cari Barthe
Vice President, Human Resources
People
Ann Rubbe
Director Of Oncology Marketing & Training

Unlock access to complete

Funding Insights of Secura Bio

Secura Bio has successfully raised a total of $55M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $55 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $55.0M
  • First Round

    (13 Mar 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2019 Amount Debt – Conventional - Secura Bio Valuation

investors

Mar, 2019 Amount Series A - Secura Bio Valuation Athyrium Capital Management
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Secura Bio

Secura Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Global private equity investments are managed by the firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Secura Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Secura Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Secura Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Secura Bio

Secura Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Abacus Medicine, STATinMED Research and Hylant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of healthcare marketing services
domain founded_year HQ Location
Marketing services to the pharmaceutical industry are provided.
domain founded_year HQ Location
Consulting services for market access, health economics and outcomes research
domain founded_year HQ Location
Healthcare data analytics services provider
domain founded_year HQ Location
Offers business insurance, employee benefits, and risk consulting services worldwide.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Secura Bio

When was Secura Bio founded?

Secura Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is Secura Bio located?

Secura Bio is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.

Is Secura Bio a funded company?

Secura Bio is a funded company, having raised a total of $55M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $50M, raised on Mar 13, 2019.

What does Secura Bio do?

Secura Bio was founded in 2018 and is based in Henderson, United States. Services in market access and health outcomes consulting are offered within the pharmaceutical sector. Focus is placed on FARYDAK, a panobinostat capsule capsule utilized for multiple myeloma treatment. Operations emphasize support for drug commercialization and outcomes research in the biotech industry.

Who are the top competitors of Secura Bio?

Secura Bio's top competitors include OPEN Health, Abacus Medicine and Target RWE.

What products or services does Secura Bio offer?

Secura Bio offers COPIKTRA.

Who are Secura Bio's investors?

Secura Bio has 1 investor. Key investors include Athyrium Capital Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available